[go: up one dir, main page]

ZA806192B - Isolation of syn-7-(2-(2-amino-4-thiazol)-2-methoxyimino) acetamido-3-acetoxymethyl-3-cephem-4-carboxylic acid - Google Patents

Isolation of syn-7-(2-(2-amino-4-thiazol)-2-methoxyimino) acetamido-3-acetoxymethyl-3-cephem-4-carboxylic acid

Info

Publication number
ZA806192B
ZA806192B ZA00806192A ZA806192A ZA806192B ZA 806192 B ZA806192 B ZA 806192B ZA 00806192 A ZA00806192 A ZA 00806192A ZA 806192 A ZA806192 A ZA 806192A ZA 806192 B ZA806192 B ZA 806192B
Authority
ZA
South Africa
Prior art keywords
cephem
methoxyimino
acetoxymethyl
acetamido
thiazol
Prior art date
Application number
ZA00806192A
Other languages
English (en)
Inventor
B Jackson
D Gardner
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ZA806192B publication Critical patent/ZA806192B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/02—Preparation
    • C07D501/12—Separation; Purification
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/26—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
    • C07D501/34—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group with the 7-amino radical acylated by carboxylic acids containing hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA00806192A 1979-10-09 1980-10-07 Isolation of syn-7-(2-(2-amino-4-thiazol)-2-methoxyimino) acetamido-3-acetoxymethyl-3-cephem-4-carboxylic acid ZA806192B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/082,822 US4252951A (en) 1979-10-09 1979-10-09 Isolation of syn-7-(2-amino-4-thiazolyl)-(methoxyimino)acetamido-3-acetoxymethyl-3-cephem-4-carboxylic acid

Publications (1)

Publication Number Publication Date
ZA806192B true ZA806192B (en) 1982-05-26

Family

ID=22173679

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA00806192A ZA806192B (en) 1979-10-09 1980-10-07 Isolation of syn-7-(2-(2-amino-4-thiazol)-2-methoxyimino) acetamido-3-acetoxymethyl-3-cephem-4-carboxylic acid

Country Status (27)

Country Link
US (1) US4252951A (xx)
EP (1) EP0027050B1 (xx)
JP (1) JPS5661388A (xx)
KR (1) KR840000866B1 (xx)
AT (1) AT369008B (xx)
AU (1) AU6306180A (xx)
BE (1) BE885569A (xx)
CA (1) CA1146539A (xx)
CH (1) CH647523A5 (xx)
CS (1) CS215142B2 (xx)
DD (1) DD153375A5 (xx)
DE (1) DE3065181D1 (xx)
DK (1) DK424680A (xx)
ES (1) ES8201166A1 (xx)
FI (1) FI803200L (xx)
FR (1) FR2467211A1 (xx)
GB (1) GB2059966B (xx)
GR (1) GR70219B (xx)
HU (1) HU183230B (xx)
IE (1) IE50390B1 (xx)
IL (1) IL61227A (xx)
IT (1) IT1132926B (xx)
PH (1) PH15023A (xx)
PT (1) PT71886B (xx)
RO (1) RO80664B (xx)
YU (1) YU256480A (xx)
ZA (1) ZA806192B (xx)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS588086A (ja) * 1981-07-07 1983-01-18 Takeda Chem Ind Ltd セフアロスポリン溶媒和物およびその製造法
JPH08831B2 (ja) * 1985-09-20 1996-01-10 富山化学工業株式会社 セファロスポリンの精製法
JPH07116200B2 (ja) * 1985-09-20 1995-12-13 富山化学工業株式会社 セファロスポリンの製造方法
EP1905757A1 (en) * 1999-04-06 2008-04-02 Sepracor Inc. Derivatives of Venlafaxine and methods of preparing and using the same
AU6731100A (en) * 1999-09-02 2001-04-10 Shionogi & Co., Ltd. Integrase inhibitors containing aromatic heterocycle derivatives
CA2284459C (en) 1999-10-04 2012-12-11 Neokimia Inc. Combinatorial synthesis of libraries of macrocyclic compounds useful in drug discovery
WO2001051454A1 (en) * 2000-01-13 2001-07-19 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
DE60228941D1 (en) * 2001-03-08 2008-10-30 Univ Pennsylvania Faciale amphiphile polymere als antiinfektiöse mittel
WO2003017949A2 (en) * 2001-08-29 2003-03-06 Neose Technologies, Inc. Novel synthetic ganglioside derivatives and compositions thereof
WO2004026817A1 (ja) * 2002-09-19 2004-04-01 Kyorin Pharmaceutical Co., Ltd. アミノアルコール誘導体とその付加塩及び免疫抑制剤
US7056916B2 (en) * 2002-11-15 2006-06-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments for the treatment of chronic obstructive pulmonary disease
EP2471525A3 (en) * 2003-03-17 2012-12-12 The Trustees Of The University Of Pennsylvania Facially amphiphllic polymers and oligomers and uses thereof
US7321065B2 (en) * 2003-04-18 2008-01-22 The Regents Of The University Of California Thyronamine derivatives and analogs and methods of use thereof
US20050203184A1 (en) * 2003-09-10 2005-09-15 Petasis Nicos A. Benzo lipoxin analogues
CN1922133A (zh) 2004-01-23 2007-02-28 宾夕法尼亚州大学理事会 表面两亲性聚芳基和聚芳基炔基聚合物和低聚物及其用途
US7825278B2 (en) * 2004-05-06 2010-11-02 The Regents Of The University Of California Substituted enaminones, their derivatives and uses thereof
US7220742B2 (en) * 2004-05-14 2007-05-22 Boehringer Ingelheim International Gmbh Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
US20050255050A1 (en) * 2004-05-14 2005-11-17 Boehringer Ingelheim International Gmbh Powder formulations for inhalation, comprising enantiomerically pure beta agonists
TWI403334B (zh) * 2004-12-23 2013-08-01 Merck Sharp & Dohme 包含生物素殘基之抗血栓雙重抑制劑
EP2301349A2 (en) * 2005-02-25 2011-03-30 The Trustees of The University of Pennsylvania Facially amphiphilic polymers and oligomers, compositions thereof, and use thereof in methods of treating cancer
KR101270841B1 (ko) * 2005-02-28 2013-06-05 가부시키가이샤 메이지 히드로퀴논 장쇄 유도체 및／또는 페녹시 장쇄 유도체 및 이들을 함유하는 의약
KR20080088570A (ko) * 2005-08-10 2008-10-02 더 존스 홉킨스 유니버시티 항기생충 및 항암 치료제 및 라이신-특이적인 디메틸라제억제제로 유용한 폴리아민
JP5270343B2 (ja) * 2005-08-15 2013-08-21 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ベータミメティックスの製造方法
US8592433B2 (en) * 2005-10-28 2013-11-26 Advait Nagle Compounds and compositions as protein kinase inhibitors
EP1954259A2 (en) * 2005-11-29 2008-08-13 Hammersmith Imanet, Ltd Amidine derivatives for in vivo imaging
ES2288107B1 (es) * 2006-01-27 2008-11-01 Fundacion Imabis Instituto Mediterraneo Para El Avance De La Biotecnologia Y La Investigacion Sanita Derivados aciclicos saturados e insaturados de cadena larga de sulfamidas como activadores especificos de receptores ppar-alfa.
US20090075935A1 (en) * 2006-07-03 2009-03-19 L'oreal Composition comprising at least one c-glycoside derivative and at least one hyaluronic acid and its cosmetic use
FR2903004B1 (fr) * 2006-07-03 2009-07-10 Oreal Utilisation en cosmetique d'un derive c-glycoside en association avec de l'acide ascorbique
FR2902996B1 (fr) * 2006-07-03 2008-09-26 Oreal Compositions cosmetiques associant un derive c-glycoside et un derive n-acylaminoamide
FR2902999B1 (fr) * 2006-07-03 2012-09-28 Oreal Utilisation de derives c-glycoside a titre d'actif prodesquamant
AU2007334428B2 (en) * 2006-12-14 2014-05-29 Teva Pharmaceutical Industries, Ltd. Crystalline solid rasagiline base
CN104844678B (zh) * 2007-05-11 2018-02-09 香港科技大学 具有神经保护和增强记忆活性的受体调节剂
US7696383B2 (en) * 2007-06-26 2010-04-13 Solvay Pharmaceuticals B.V. N-oxides of venlafaxine and o-desmethylvenlafaxine as prodrugs
FR2920000B1 (fr) * 2007-08-13 2010-01-29 Oreal Composition cosmetique ou pharmaceutique contenant de l'acide hyaluronique, et procede cosmetique pour diminuer les signes du vieilissement
ATE543799T1 (de) * 2007-10-19 2012-02-15 Janssen Pharmaceutica Nv Piperidinyl- und piperazinylmodulatoren von g- sekretase
AU2008312371B2 (en) * 2007-10-19 2013-06-20 Janssen Pharmaceutica, N.V. Amine linked modulators of gamma-secretase
EP2215043B1 (en) * 2007-10-19 2013-03-06 Janssen Pharmaceutica, N.V. Carbon linked modulators of y-secretase
EP2093207A1 (en) * 2008-02-06 2009-08-26 Julius-Maximilians-Universität Würzburg Antiinfective and antitumoral compounds isolated from tropical lianas
US8063249B1 (en) * 2008-04-25 2011-11-22 Olema Pharmaceuticals, Inc. Substituted triphenyl butenes
WO2010017328A2 (en) * 2008-08-06 2010-02-11 Rgo Biosciences Llc Cyclodextrin conjugates
JP5773877B2 (ja) * 2008-10-22 2015-09-02 アキュセラ インコーポレイテッド 眼の疾患及び障害を治療する化合物
FR2940610B1 (fr) * 2008-12-30 2011-05-06 Oreal Association de monosaccharides avec des derives c-glycosides et son utilisation en cosmetique
EP2410846B1 (en) 2009-03-25 2016-09-07 Seneb Biosciences, Inc. Glycolipids as treatment for disease
CN104016987A (zh) * 2009-05-14 2014-09-03 米伦纽姆医药公司 氨基磺酸((1s,2s,4r)-4-{4-[(1s)-2,3-二氢-1h-茚-1-基氨基]-7h-吡咯并[2,3-d]嘧啶-7-基}-2-羟基环戊基)甲酯盐酸盐
WO2010138828A2 (en) * 2009-05-29 2010-12-02 Abbott Laboratories Potassium channel modulators
US8288592B2 (en) * 2009-09-22 2012-10-16 Actavis Group Ptc Ehf Solid state forms of tapentadol salts
US8609674B2 (en) 2010-11-16 2013-12-17 Abbvie Inc. Potassium channel modulators
EP2753317B1 (en) * 2011-09-06 2020-02-26 CuRNA, Inc. TREATMENT OF DISEASES RELATED TO ALPHA SUBUNITS OF SODIUM CHANNELS, VOLTAGE-GATED (SCNxA) WITH SMALL MOLECULES
US8377946B1 (en) * 2011-12-30 2013-02-19 Pharmacyclics, Inc. Pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyrimidine compounds as kinase inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3925372A (en) * 1973-02-23 1975-12-09 Lilly Co Eli Alpha-aminoacyl-3-halo cephalosporins
DK154939C (da) * 1974-12-19 1989-06-12 Takeda Chemical Industries Ltd Analogifremgangsmaade til fremstilling af thiazolylacetamido-cephemforbindelser eller farmaceutisk acceptable salte eller estere deraf
DE2760123C2 (de) * 1976-01-23 1986-04-30 Roussel-Uclaf, Paris 7-Aminothiazolyl-syn-oxyiminoacetamidocephalosporansäuren, ihre Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
US4166115A (en) * 1976-04-12 1979-08-28 Fujisawa Pharmaceutical Co., Ltd. Syn 7-oxoimino substituted derivatives of cephalosporanic acid

Also Published As

Publication number Publication date
CH647523A5 (fr) 1985-01-31
IT1132926B (it) 1986-07-09
DK424680A (da) 1981-04-10
IL61227A (en) 1983-07-31
PT71886A (en) 1980-11-01
AT369008B (de) 1982-11-25
HU183230B (en) 1984-04-28
ES495753A0 (es) 1981-12-01
AU6306180A (en) 1981-04-16
IE50390B1 (en) 1986-04-16
PH15023A (en) 1982-05-13
RO80664B (ro) 1983-02-28
IE802086L (en) 1981-04-09
IL61227A0 (en) 1980-12-31
FR2467211A1 (fr) 1981-04-17
KR840000866B1 (ko) 1984-06-20
GB2059966A (en) 1981-04-29
YU256480A (en) 1983-02-28
RO80664A (ro) 1983-02-15
GB2059966B (en) 1983-09-01
ATA498080A (de) 1982-04-15
ES8201166A1 (es) 1981-12-01
JPS5661388A (en) 1981-05-26
EP0027050B1 (en) 1983-10-05
FR2467211B1 (xx) 1983-06-10
DD153375A5 (de) 1982-01-06
CS215142B2 (en) 1982-07-30
FI803200L (fi) 1981-04-10
CA1146539A (en) 1983-05-17
PT71886B (en) 1981-08-13
GR70219B (xx) 1982-08-31
IT8025200A0 (it) 1980-10-08
BE885569A (fr) 1981-04-08
EP0027050A1 (en) 1981-04-15
DE3065181D1 (en) 1983-11-10
KR830004314A (ko) 1983-07-09
US4252951A (en) 1981-02-24

Similar Documents

Publication Publication Date Title
ZA806192B (en) Isolation of syn-7-(2-(2-amino-4-thiazol)-2-methoxyimino) acetamido-3-acetoxymethyl-3-cephem-4-carboxylic acid
IL60957A (en) Preparation of 1-amino-cyclopropane-carboxylic acid compounds
GB2055357B (en) Process for the preparation of crystalline silicates
PT71990B (en) Process for the isolation of gallery constructions
JPS55167248A (en) Manufacture of alkoxyalkanoic acid
RO85323B (ro) Procedeu pentru prepararea unor fenoxiamine heterociclice
DE3064088D1 (en) Process for the preparation of 4-nitrotoluene-2-sulfonic acid
DE3065967D1 (en) Process for the preparation of diorganomagnesium compounds
JPS5683492A (en) Manufacture of 77aminodesacetoxycephalosporanic acid derivative
JPS56121493A (en) Preparation of micophenol acid derivative
JPS568359A (en) Manufacture of heterocyclic compound
JPS5673050A (en) Isolation of amino acid
DE3062386D1 (en) Process for the preparation of 3-hydroxycepham compounds
JPS56118058A (en) Manufacture of 22aminoo11naphthalenesulfonic acid
IL58287A (en) Process for the preparation of 3-carbamoyloxymethyl cephalosporin compounds
JPS5695146A (en) Manufacture of isoethylacetic acid
IT7967593A0 (it) Procedimento per la fabbrica ione di pezzi di allumina beta alcalina
JPS55139386A (en) Manufacture of 66betaaamidinopenicillanic acid derivative
JPS55147245A (en) Manufacture of omegaaamino acid
JPS55118461A (en) Manufacture of 66chlorooalphaamethyll carbazolee22acetic acid
JPS5692292A (en) Nnsubstituted thiazolyl derivative of 77aminocephalosporanic acid
JPS5616437A (en) Manufacture of alphaaarylpropionic acid
DE3060188D1 (en) Process for the preparation of 3-phenoxy-4-fluoro-benzoic acid
JPS5692861A (en) Carbothio acid derivative of mercaptoacylamino acid
YU250580A (en) Process for obtaining acylhydrazoneesters of formylacetic acid